Expert advises strict adherence to HIV medication for healthy well-being

Mr Idowu Orogbemi, the Clinical Director, AIDS Health Care Foundation, an NGO, on Tuesday, advised persons living with HIV to adhere strictly to their HIV medication to live healthily.

He gave the advice in an interview with the News Agency of Nigeria (NAN) in Abuja, saying that Anti-Retroviral (ARV) medications were used to increase the health and well-being of people living with HIV.

He added that the National Guideline for HIV prevention, treatment and care recommends ARV treatment for all people living with HIV and AIDS.

He explained that HIV medication adherence means taking ARV drugs exactly as prescribed by healthcare personnel.

“This includes taking the medication at the right time to ensure that the concentration of drug in the body does not drop below the minimum needed to fight HIV daily.

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below

Laboratory Order Forms

Start typing and press enter to search